Synovial Fibroblast 3.2: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis-diagnosed donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 2 of 2) - Dataset (ID:20235)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA1869 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | MIP-1A | 97.0 | 41 | |
RA1869 | IL-1 alpha | 100 | ng/mL | 1 | MIP-1A | 189.0 | 42 | ||||
N2759 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | MIP-1A | 476.0 | 41 | |
N2759 | IL-1 alpha | 100 | ng/mL | 1 | MIP-1A | 380.0 | 34 | ||||
RA1931 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | MIP-1A | 82.5 | 44 | |
RA1931 | IL-1 alpha | 100 | ng/mL | 1 | MIP-1A | 231.5 | 48 | ||||
N2586 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | MIP-1A | 255.5 | 38 | |
N2586 | IL-1 alpha | 100 | ng/mL | 1 | MIP-1A | 220.0 | 40 | ||||
RA1869 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 1 | MIP-1A | 18.0 | 40 | |
RA1869 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 1 | MIP-1A | 19.0 | 65 | |
N2759 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 1 | MIP-1A | 21.0 | 56 | |
N2759 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 1 | MIP-1A | 21.5 | 60 | |
RA1931 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 1 | MIP-1A | 19.0 | 54 | |
RA1931 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 1 | MIP-1A | 23.0 | 47 | |
N2586 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 1 | MIP-1A | 24.0 | 43 | |
N2586 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 1 | MIP-1A | 24.0 | 43 | |
RA1869 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 1 | MIP-1A | 27.0 | 42 | |
RA1869 | Poly(I:C) | 2 | ug/mL | 1 | MIP-1A | 93.0 | 46 | ||||
N2759 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 1 | MIP-1A | 258.0 | 34 | |
N2759 | Poly(I:C) | 2 | ug/mL | 1 | MIP-1A | 395.0 | 43 | ||||
RA1931 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 1 | MIP-1A | 1169.5 | 42 | |
RA1931 | Poly(I:C) | 2 | ug/mL | 1 | MIP-1A | 18.0 | 41 | ||||
N2586 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 1 | MIP-1A | 333.0 | 39 | |
N2586 | Poly(I:C) | 2 | ug/mL | 1 | MIP-1A | 267.0 | 55 | ||||
RA1869 | 5z-7-oxozeaenol | 0.6 | uM | 1 | MIP-1A | 17.0 | 38 |